Cellply
Cellply develops the VivaCyte platform, an analytical system designed for the discovery and process development of cell therapies. The technology enables automated characterization of immune cells at single-cell resolution, integrating sample preparation and image processing for research applications. The system supports high-throughput analysis of over 100 samples per run to evaluate immune system function.
Healthtech
Biotechnology
Life Sciences
Funding summary
- Total raised
- €15.6M
- Funding rounds
- 5
Investors in Cellply
Investors on record for Cellply. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Cellply?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors